Home >
Medicine Info >
Polaramine 2 mg Tablet
Loading interface...

Polaramine 2 mg Tablet

Manufactured byFulford (India) Ltd.
ContainsDexchlorpheniramine
Description
Polaramine 2 mg Tablet is an antihistamine medicine, which is used to prevent or treat allergic reactions like hay fever or urticaria caused by pollen, dust, or animal hair. It is also used to treat common cold symptoms.
QUICK LINKS:
Side effectsConcernsUsageRelated products

Substitutes

List of substitutes for Polaramine 2 mg Tablet

Polostan 2 mg Tablet
Mankind Pharmaceuticals Ltd.

Side effects

Major & minor side effects for Polaramine 2 mg Tablet

  • Sleepiness or unusual drowsiness
  • Blurred vision
  • Dry mouth
  • Heart Rhythm disorders

Uses of Polaramine 2 mg Tablet

What is it prescribed for?

  • Allergic conditions
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The amount of time required for this medicine to show its action is not clinically established.
  • How long do the effects of this medicine last?
    The amount of time for which this medicine remains active in the body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of side effects such as dizziness, drowsiness, and difficulty in concentration. It is advised that you do not perform any activities that require high mental alertness like driving a vehicle or operating machinery if you consume alcohol during treatment with this medicine.
  • Is this a habit forming medicine?
    No habit-forming tendencies were reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless necessary. The risks and benefits should be discussed with the doctor before taking this medicine.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless necessary. The risks and benefits should be discussed with the doctor before taking this medicine.

Allergy

This medicine is not recommended for use if you have a known allergy to dexchlorpheniramine, or any other inactive ingredients present in the formulation.

Neonates and premature infants

This medicine is not recommended for use in neonates and premature infants less than 2 years of age due to the increased risk of serious adverse effects.

Benign prostatic hyperplasia

This medicine is not recommended for use in patients suffering from benign prostatic hyperplasia due to the increased risk of worsening of the patient's condition.

Monoamine oxidase inhibitors (MAOI)

This medicine is not recommended if the patient has taken MAO inhibitors like selegiline or rasagiline within the last 14 days. Their combination may increase the risk of adverse effects like drowsiness, blurred vision, as well as a life-threatening condition called serotonin syndrome.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless necessary. The risks and benefits should be discussed with the doctor before taking this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless necessary. The risks and benefits should be discussed with the doctor before taking this medicine.
General warnings

Use in elderly

This medicine should be used with caution in individuals who are 60 years old and above due to an increased risk of dizziness, drowsiness, and low blood pressure. Appropriate dose adjustments should be made under your doctor's supervision.

Use in children

This medicine is not recommended for use in children under the age of 2 years due to the risk of serious side effects.

Gastrointestinal blockage

This medicine should be used with extreme caution in patients with a gastrointestinal obstruction due to the increased risk of worsening of the patient's condition. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition of the patient.

Glaucoma

This medicine should be used with extreme caution in patients with glaucoma since it may increase the intraocular pressure, leading to an increased risk of vision problems. This risk is especially higher in elderly patients.

Driving or operating machinery

This medicine may cause dizziness or drowsiness in some patients. It is advised that you do not perform any activities that require high mental alertness like a vehicle or operating machinery if you experience any of these symptoms during treatment with this medicine.

Missed Dose

Take the missed dose as soon as you remember. If it is almost time for the next scheduled dose, skip the missed dose. Do not double your dose to make up for the missed dose.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

N/A

Instructions

Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of side effects such as dizziness, drowsiness, and difficulty in concentration. It is advised that you do not perform any activities that require high mental alertness like driving a vehicle or operating machinery if you consume alcohol during treatment with this medicine.
Interaction with Medicine

Isocarboxazid

Amitriptyline

Clobazam

Baclofen

Loperamide

Perphenazine

Disease interactions

Liver Disease

This medicine should be used with caution in patients with liver diseases due to the increased risk of severe adverse effects. Close monitoring of liver function tests, appropriate dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

Kidney disease

This medicine should be used with caution in patients with kidney diseases due to the increased risk of severe adverse effects. Close monitoring of kidney function, appropriate dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

Asthma

This medicine should be used with extreme caution in patients with asthma/COPD since it may increase the risk of lung problems like respiratory tract blockage. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition of the patient.

Cardiovascular disease

This medicine should be used with extreme caution in patients with cardiovascular diseases due to the increased risk of severe side effects. Report any incidence of irregular heart rate and very high blood pressure to the doctor on priority. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition of the patient.
Food interactions
Information not available.
Lab interactions
Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.
Take this medicine as instructed by the doctor. Do not take in larger amounts than advised/prescribed. Consult the doctor if you experience any undesirable effects. Do not stop taking the medicine before completion of the course/without consulting your doctor.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

May cause sleepiness

How it works
This medicine blocks the action of certain substances produced by the body which induce allergic reactions.
Legal Status

Approved

Approved

Unknown

Unknown

Classification

Category

Antihistamines

Schedule

Schedule H

Dexchlorpheniramine maleate - DrugBank [Internet]. Drugbank.ca. 2020 [cited 28 April 2020]. Available from:

https://www.drugbank.ca/drugs/DB09555

[Internet]. Medsafe.govt.nz. 2020 [cited 28 April 2020]. Available from:

https://www.medsafe.govt.nz/Profs/Datasheet/p/Polaraminetabreptabsyrup.pdf

Dexchlorpheniramine [Internet]. Pubchem.ncbi.nlm.nih.gov. 2020 [cited 28 April 2020]. Available from:

https://pubchem.ncbi.nlm.nih.gov/compound/Dexchlorpheniramine
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 1 Jun 2020

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.